9 June 2020, Barcelona, Spain

Bert has more than 20 years of experience in the development of Class III implantable medical devices and his expertise has been instrumental in bringing key innovation in the neuromodulation space to a commercialization phase.

In his role as CTO and INBRAIN’s leadership member he will be responsible of the strategic development and execution of INBRAIN’s graphene core technology designed to decode brain signals into medical solutions in the field of neuroelectronic therapies with the objective to restore patient’s quality of life in those affected with brain-origin disorders.

“Seeing so many people struggling with their lives caused by health issues, being a technology person, my job becomes a life mission. This opportunity at INBRAIN brings me a way to help improving people’s quality of life by bringing technology which is beneficial to many. I am very excited and grateful for this opportunity offered by INBRAIN and I look forward to develop together with the team and partners graphene-based medical devices which make a difference” said B. Bakker.

Prior to joining INBRAIN, Bert was CTO of GTXmedical a MedTech company focused on the development and commercialization of innovative therapies to accelerate and augment functional recovery of people with spinal cord injury and to improve their quality of life. At GTX Bert helped bring forward their implantable neuromodulation system as well as the platform components around.

Before GTX Bert had several positions in other important MedTech companies such as Philips, Sapiens Steering Stimulation and Medtronic after Sapiens acquisition. Bert holds a master’s degree in electrical engineering from the Eindhoven University of Technology in The Netherlands.

“We are extremely proud of having Bert on board and we are convinced that his experience and leadership style will be key success contributors for the company and its impact in the European MedTech ecosystem to keep translating revolutionary technology into solutions to people with brain disorders” said Jose A. Garrido, Chief Scientific Officer & Founder of INBRAIN with Carolina Aguilar, Chief Executive Officer and Co- Founder of INBRAIN.